Ritonavir-boosted double?protease inhibitor (PI)?only regimens are such an option but are prone to pharmacokinetic interactions.

• 单独的利托那韦用量增加的双蛋白酶抑制剂（PI）疗法正是其中之一，但在药代动力学上两者易于产生相互作用。